ADHD and Addiction: A Growing Concern and Integrated Approach
A new guide released by the Interministerial Delegation for the National Strategy for Neurodevelopmental Disorders (Autism, Dys, ADHD, DID) and the Interministerial Mission to Combat Drugs and Addictive Behaviors (MILDECA) highlights a significant link between Attention-Deficit/Hyperactivity Disorder (ADHD) and addiction. The guide aims to improve identification, care coordination, and treatment for individuals facing both challenges.
The Connection Between ADHD and Addiction
Affecting approximately 5% of children and adolescents and 3% of adults, ADHD often remains undiagnosed, particularly in girls. Research indicates a strong association between ADHD and addictive behaviors. A study published in 2025 in the Annales Médico-psychologique found that 23% of individuals with substance addiction also have ADHD, rising to 40% in cases of non-substance addiction. Conversely, up to 50% of individuals with ADHD experience some form of addiction [Source].
The guide emphasizes that undiagnosed or untreated ADHD is a major risk factor for developing addictive disorders. Impulsivity, sensation-seeking, and emotional dysregulation – common symptoms of ADHD – can contribute to early initiation and progression of addiction, often leading to more severe outcomes. Addictive substances can mask or exacerbate ADHD symptoms, creating a complex interplay between the two conditions.
Three Key Objectives of the New Guide
The guide focuses on three primary objectives:
- Improving the identification of ADHD in individuals with addictive disorders.
- Promoting coordinated and integrated care pathways between addiction specialists and neurodevelopmental professionals.
- Disseminating best practices based on scientific recommendations and the needs of individuals.
Tools for Identifying ADHD in Individuals with Addiction
The guide recommends two key tools for identification:
- Adult Self Report Scale (ASRS-18): A questionnaire developed by the World Health Organization to screen for potential ADHD symptoms.
- Wender Utah Rating Scale (WURS-25): A retrospective assessment tool used to reconstruct a historical profile of ADHD symptoms from childhood.
Regular individual interviews are also recommended, when possible, to explore current and past functioning. Gathering information from individuals who knew the patient during childhood can be particularly valuable.
Treatment Approaches: A Multimodal Strategy
Effective ADHD care typically involves a multimodal and multidisciplinary approach, combining both pharmacological and non-pharmacological strategies. Addiction professionals should be vigilant for potential interactions between addictive substances and ADHD medications, particularly stimulants. Initiating medication in a hospital setting may be considered to mitigate risks, and specialized care networks are crucial for ongoing monitoring.
Given that first-time prescriptions for ADHD medication are not authorized for addiction specialists, centers without a psychiatrist must collaborate with one to confirm the diagnosis and initiate treatment. The guide also stresses the importance of combining medication with non-pharmacological interventions, such as psychoeducation and cognitive-behavioral therapies, which are often underutilized.
A Broader Movement Towards Integrated Care
This guide is part of a larger effort to improve ADHD identification and understanding within addiction care and prevention centers (CSAPA). The goal is to empower all professionals to support individuals with co-occurring ADHD and addiction through psychoeducation and involvement in treatment decisions [Source].
As stated by Étienne Pot, interministerial delegate for the national strategy for neurodevelopmental disorders, and Nicolas Prisse, president of MILDECA, the current challenge lies in encouraging full professional engagement in supporting affected individuals.